Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library.
about
Engineering therapeutic antibodies targeting G-protein-coupled receptorsHLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic RatsSelection of phage-displayed fab antibodies on the active conformation of ras yields a high affinity conformation-specific antibody preventing the binding of c-Raf kinase to Ras.Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault proteinUse of proteoliposomes to generate phage antibodies against native AMPA receptor.By-passing selection: direct screening for antibody-antigen interactions using protein arraysAntibody arrays for high-throughput screening of antibody-antigen interactions.Identification of CD4 and transferrin receptor antibodies by CXCR4 antibody-guided Pathfinder selection.An efficient strategy for cell-based antibody library selection using an integrated vector system.Recombinant antibodies: a novel approach to cancer diagnosis and therapy.An antibody library for stabilizing and crystallizing membrane proteins - selecting binders to the citrate carrier CitS.Peptides selected for binding to a virulent strain of Haemophilus influenzae by phage display are bactericidal.Deconvolution of a complex target using DNA aptamers.Mining a yeast library for brain endothelial cell-binding antibodies.A novel strategy for proteome-wide ligand screening using cross-linked phage matricesFully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.Discovery of internalizing antibodies to tumor antigens from phage libraries.Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.Selection and characterization of cell binding and internalizing phage antibodies.Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selectionAntibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining.Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology.The isolation of novel phage display-derived human recombinant antibodies against CCR5, the major co-receptor of HIVA novel heavy domain antibody library with functionally optimized complementarity determining regions.Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display.Targeting membrane proteins for antibody discovery using phage display.High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells.Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.Targeting of phage particles towards endothelial cells by antibodies selected through a multi-parameter selection strategy.Escherichia coli surface display for the selection of nanobodies.Going native: Direct high throughput screening of secreted full-length IgG antibodies against cell membrane proteins.Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes.PRODUCTION AND ANALYTICAL APPLICATIONS OF scFv ANTIBODY FRAGMENTS
P2860
Q26769017-59C6D012-BAA7-4567-928E-2442BDF81F65Q27303777-E7BE2D51-DB2A-40B4-A7F4-F13423479B41Q30827772-6FA49266-A79D-4E67-A7FA-EEE19BDF1ADAQ30832090-A3F966AA-1D5C-4B56-AF49-B77556667311Q30842128-49056B3F-590E-4B23-B6D4-82BB071528ECQ30887325-2BE8E2DA-7CDD-4AA8-9F37-5828F46C55DBQ30918339-32635280-C435-4D7B-A19B-BC7AF6FA4575Q31026565-FD6D90C9-4923-4CF2-96AE-5640907086BFQ31091174-0B7B3BC6-9474-465F-BCB9-681C10879F06Q33181384-DCCD4D36-6541-404E-B5D8-420ADA9A43A3Q33202365-40520404-9B69-4A84-83D6-18CA2C942245Q33217973-F6D8B8D7-D52E-4060-87A6-FEAB8474D614Q33221136-0F607CC0-82CB-4A9B-B070-A81699ACB0FFQ33268344-CC4F8C93-5E64-4487-B777-B9FB3DF23F45Q33527745-85379C8A-1D24-4DB2-8B37-26FD947A812AQ33982582-EEE544F3-CD3B-48D4-8BAD-DD101FF075E9Q34114794-E0C87CA9-33E4-4B0F-ABF1-68B99F8C52ADQ34265730-061672FA-9548-41ED-B4C3-0227A053EBD4Q34280931-357F2BC9-6A7C-44F0-8186-DEB4F9B50393Q34287677-8118DD1B-4861-4C10-94D1-3BB61D135F74Q34417503-2962390F-FDEE-46C4-BCCD-5818A3DFA2FDQ34560363-73910DB7-0929-4982-8055-97918E7C890CQ34939533-666B3276-8BF9-4377-A65E-BE1AE3766A8EQ35014937-28DC4D9D-5799-47AD-A686-419E6942F87EQ35628801-D43FC822-4741-44AA-BC8B-875FAFA71BF7Q36020577-2B79900C-06EB-4BC9-83A5-4F7F9F3F4915Q36089600-0C46B701-E010-4A45-B4DC-29263B8A7FF6Q37376200-A25C421D-254B-4620-A690-B8FD71ED9297Q39270763-88B3A332-CB62-47AE-A9B4-C07464DEF36CQ42322516-0B82DC5C-1C89-49F0-A32F-4642BB2E9D5CQ42770832-5D31F884-D790-4009-B0DF-608F364DDB05Q49965756-93042783-B1F6-41AE-B710-243DB9668EDEQ55312558-B5AB9F6F-6F55-4950-BE94-E767680F0B42Q58179455-A7335990-8484-412E-8862-E163157C6D91
P2860
Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Selection-dominant and nonacce ...... large phage antibody library.
@ast
Selection-dominant and nonacce ...... large phage antibody library.
@en
type
label
Selection-dominant and nonacce ...... large phage antibody library.
@ast
Selection-dominant and nonacce ...... large phage antibody library.
@en
prefLabel
Selection-dominant and nonacce ...... large phage antibody library.
@ast
Selection-dominant and nonacce ...... large phage antibody library.
@en
P2093
P1433
P1476
Selection-dominant and nonacce ...... large phage antibody library.
@en
P2093
A De Bruïne
F A Van Nieuwenhoven
H R Hoogenboom
J T Lutgerink
J W Arends
M J Rousch
M M Pelsers
N Van Neer
P304
P356
10.1046/J.1432-1327.1999.00214.X
P407
P577
1999-03-01T00:00:00Z